Back
IGC Pharma 10K Form
Sell
28
IGC
IGC Pharma
Last Price:
0.35
Seasonality Move:
-9.08%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IGC News And Ratings
See the #1 stock for the next 7 days that we like better than IGC
IGC Financial Statistics
Sales & Book Value
| Annual Sales: | $1.35M |
|---|---|
| Cash Flow: | $-1.08M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.10 |
| Price / Book: | 3.69 |
Profitability
| EPS (TTM): | -0.18000 |
|---|---|
| Net Income (TTM): | $-12.57M |
| Gross Margin: | $733K |
| Return on Equity: | -137.43% |
| Return on Assets: | -107.19% |
IGC Pharma Earnings Forecast
Key IGC Pharma Financial Ratios
- The Gross Profit Margin over the past 17 years for IGC is 54.50%.
- The Selling, General & Administrative Expenses for IGC have been equal to 502.45% of Gross Profit Margin.
- The Research & Development expenses have been 280.52% of Revenue.
- The Interest Expense is -1.68% of Operating Income.
- The Net Earning history of IGC is -966.54% of Total Revenues.
- Per Share Earnings over the last 19 years have been positive in 9 years.
IGC Pharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | IGC |
| CUSIP: | 45408X |
| Website: | igcinc.us |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 1.52 |
| Quick Ratio: | 0.58 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
IGC Technical Analysis vs Fundamental Analysis
Sell
28
IGC Pharma (IGC)
is a Sell
Is IGC Pharma a Buy or a Sell?
-
IGC Pharma stock is rated a Sell
The current IGC Pharma [IGC] share price is $0.33. The Score for IGC is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.